Published in Contemp Urol on May 01, 1993
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med (1998) 12.67
Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol (2000) 3.39
The epidemiology of erectile dysfunction. Urol Clin North Am (1995) 3.11
Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology (1985) 1.93
Penile length in the flaccid and erect states: guidelines for penile augmentation. J Urol (1996) 1.85
Bladder injection of "naked" hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Am J Physiol Regul Integr Comp Physiol (2001) 1.83
Hemodynamics of papaverine- and phentolamine-induced penile erection. J Urol (1986) 1.74
Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res (2003) 1.68
Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol (1998) 1.66
Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. Br J Urol (1997) 1.64
Complications of penile lengthening and augmentation seen at 1 referral center. J Urol (1996) 1.64
Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol (1984) 1.60
Effect of simulated birth trauma on the urinary continence mechanism in the rat. Urology (1998) 1.59
The effect of simulated birth trauma and/or ovariectomy on rodent continence mechanism. Part I: functional and structural change. J Urol (2001) 1.53
Accuracy of the initial history and physical examination to establish the etiology of erectile dysfunction. Urology (1995) 1.45
Priapism: a refined approach to diagnosis and treatment. J Urol (1986) 1.42
Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol (2008) 1.42
The effect of surgical trauma on rat tunica albuginea. J Urol (1998) 1.42
Diffuse veno-occlusive dysfunction: the underlying hemodynamic abnormality resulting in failure to respond to intracavernous pharmacotherapy. J Urol (1996) 1.38
Evaluation of the impotent patient. Semin Urol (1986) 1.38
Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med (1997) 1.37
Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol (1998) 1.33
Gap junction-mediated intercellular diffusion of Ca2+ in cultured human corporal smooth muscle cells. Am J Physiol (1992) 1.31
Physiology of erection and pharmacological management of impotence. J Urol (1987) 1.30
The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int (2003) 1.29
Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol (1997) 1.28
Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol (2004) 1.25
The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res (2001) 1.25
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol (2000) 1.20
Bladder acellular matrix graft: in vivo functional properties of the regenerated rat bladder. Urol Res (1999) 1.17
An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol (1997) 1.17
Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration. J Urol (1987) 1.14
Health issues of men: prevalence and correlates of erectile dysfunction. J Urol (2005) 1.13
Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia. BJU Int (2003) 1.12
The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol (2001) 1.10
Elevated plasma levels of TGF-beta 1 in patients with invasive prostate cancer. Nat Med (1995) 1.09
Penile replantation: current concepts. J Urol (1985) 1.07
Erectile dysfunction: problems and challenges. J Urol (1993) 1.07
Peyronie's disease: a critical appraisal of current diagnosis and treatment. Int J Impot Res (2008) 1.05
Clinical significance of sacral and pudendal nerve anatomy. J Urol (1988) 1.05
Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol (2001) 1.04
The microarchitecture of the intracavernosal smooth muscle and the cavernosal fibrous skeleton. J Urol (1990) 1.03
Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoforms. BJU Int (2002) 1.03
Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J Urol (1995) 1.03
Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res (1999) 1.02
The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol (1997) 1.02
Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU Int (2000) 1.02
Expression of three isoforms of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in human penile cavernosum. Biochem Biophys Res Commun (2000) 1.01
Hemodynamics of erection in the monkey. J Urol (1983) 1.00
Anatomy of cavernous nerves distal to prostate: microdissection study in adult male cadavers. Urology (1993) 1.00
Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. Int J Impot Res (2010) 1.00
A review of erectile dysfunction: new insights and more questions. J Urol (1993) 1.00
Gap junctions between human corpus cavernosum smooth muscle cells: gating properties and unitary conductance. Am J Physiol (1993) 1.00
Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, crossover study. Int J Impot Res (2007) 0.99
Tracking intracavernously injected adipose-derived stem cells to bone marrow. Int J Impot Res (2011) 0.99
Anatomy and strength of the tunica albuginea: its relevance to penile prosthesis extrusion. J Urol (1994) 0.99
Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study. Urology (1998) 0.98
Continence mechanism of the isolated female urethra: an anatomical study of the intrapelvic somatic nerves. J Urol (1997) 0.97
The effect of pregnancy and delivery on the function and ultrastructure of the rat bladder and urethra. BJU Int (2000) 0.97
Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. Am J Physiol (1997) 0.96
Erectile dysfunction as a harbinger for increased cardiometabolic risk. Int J Impot Res (2008) 0.96
Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. DNA Cell Biol (1999) 0.96
Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol (1998) 0.96
Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest (1993) 0.96
Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. Int J Impot Res (2002) 0.95
Pathophysiology of erectile dysfunction. Urology (1993) 0.95
Nitric oxide and cGMP: mediators of pelvic nerve-stimulated erection in dogs. Am J Physiol (1993) 0.95
Insulin-like growth factor-I promotes proliferation and migration of cavernous smooth muscle cells. Biochem Biophys Res Commun (2001) 0.95
Venous patch graft for Peyronie's disease. Part II: outcome analysis. J Urol (1998) 0.94
The neuropathy of erectile dysfunction. Int J Impot Res (2002) 0.94
Identification and regulation of human PDE5A gene promoter. Biochem Biophys Res Commun (2001) 0.94
Hemodynamics of canine corpora cavernosa during erection. Urology (1984) 0.93
The correction of congenital penile curvature in young men. Br J Urol (1998) 0.92
Detailed anatomy of penile neurovascular structures: surgical significance. J Urol (1989) 0.92
Polymorphism of the insulin gene is associated with increased prostate cancer risk. Br J Cancer (2003) 0.92
Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoceptor responsiveness with age and disease in isolated tissues. Br J Pharmacol (1990) 0.92
Penile detumescence: characterization of three phases. J Urol (1991) 0.91
The effect of cigarette smoking on penile erection. J Urol (1987) 0.91
Intracavernous alprostadil alfadex (EDEX/VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology (2000) 0.91
Health outcomes variables important to patients in the treatment of erectile dysfunction. J Urol (1998) 0.91
Can a venous patch graft be a substitute for the tunica albuginea of the penis? J Urol (1993) 0.91
Radiation-induced decrease in nitric oxide synthase--containing nerves in the rat penis. Radiology (1995) 0.91
Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. J Urol (1989) 0.90
Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site. Biochem Biophys Res Commun (2001) 0.90
Free ureteral replacement in rats: regeneration of ureteral wall components in the acellular matrix graft. Urology (1997) 0.90
Effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 complex in cavernous nerve cryoablation. Int J Impot Res (2004) 0.90
Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem Biophys Res Commun (1996) 0.89
Drug-induced male sexual dysfunction. An update. Drug Saf (1993) 0.89
Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J Urol (1992) 0.89
Priapism induced by chlorpromazine and trazodone: mechanism of action. J Urol (1987) 0.88
Hemodynamics of penile erection. Urol Clin North Am (1988) 0.88
In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J Urol (1998) 0.88
Results of surgical treatment for abnormal penile curvature: Peyronie's disease and congenital deviation by modified Nesbit plication (tunical shaving and plication). J Urol (1997) 0.88
Growth factor therapy and neuronal nitric oxide synthase. Int J Impot Res (2004) 0.88
Age-related decrease of protein kinase G activation in vascular smooth muscle cells. Biochem Biophys Res Commun (2001) 0.88
Evaluation of the first 70 patients in the center for male sexual dysfunction of Beth Israel Medical Center. J Urol (1984) 0.88
Neuromuscular dysfunction in nonbacterial prostatitis. Urology (1987) 0.88